DermTech Price to Free Cash Flow Ratio 2017-2024 | DMTKQ

DermTech price to free cash flow ratio from 2017 to 2024. Price to free cash flow ratio can be defined as

DermTech Price to Free Cash Flow Ratio 2017-2024 | DMTKQ

DermTech price to free cash flow ratio from 2017 to 2024. Price to free cash flow ratio can be defined as
Related Stocks
Company NameMarket
Cap
Elevance Health (ELV)$96B
Cencora (COR)$46.2B
DiDi Global (DIDIY)$23.8B
ICON (ICLR)$18.2B
Natera (NTRA)$15.4B
Avantor (AVTR)$15.2B
Revvity (RVTY)$14.9B
Viatris (VTRS)$13.9B
BioMerieux (BMXMF)$12.8B
Solventum (SOLV)$12.5B
CochLear (CHEOY)$12.3B
Medpace Holdings (MEDP)$9.9B
Charles River Laboratories (CRL)$9.3B
Sonic Healthcare (SKHHY)$8.4B
Doximity (DOCS)$7.9B
HealthEquity (HQY)$7.5B
Bausch + Lomb (BLCO)$7.2B
PACS (PACS)$6.5B
Life Times (LTH)$4.7B
Organon (OGN)$4.7B
Sotera Health (SHC)$4.5B
Surgery Partners (SGRY)$3.7B
BrightSpring Health Services (BTSG)$3B
Concentras Parent (CON)$2.5B
Ardent Health Partners (ARDT)$2.5B
Alignment Healthcare (ALHC)$2.5B
GoodRx Holdings (GDRX)$2.3B
GeneDx Holdings (WGS)$2.1B
Premier (PINC)$2B
Ryman Healthcare (RYHTY)$1.9B